More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/SARS-CoV-2 (COVID-19) Nucleocapsid antibody

SARS-CoV-2 (COVID-19) Nucleocapsid antibody

Research Use Only
GTX135570
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
DownloadDatasheet
Product group Antibodies
ReactivityVirus
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    GeneTex
  • Product Name
    SARS-CoV-2 (COVID-19) Nucleocapsid antibody
  • Delivery Days Customer
    9
  • Antibody Specificity
    This antibody detects both SARS-CoV nucleocapsid and SARS-CoV-2 nucleocapsid proteins. Our internal testing indicates minor cross-reactivity with MERS-CoV nucleocapsid protein.
  • Application Supplier Note
    WB: 1:1000-1:10000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Formulation
    Liquid
  • Host
    Rabbit
  • Isotype
    IgG
  • Reactivity
    Virus
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Suzuki R et al., 2022 Mar, Nature
    Read more
  • Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Saito A et al., 2022 Feb, Nature
    Read more